United States of America ex rel. Dinesh S. Thakur v. Ranbaxy et al. – Key Facts 1. On May 13, 2013, Ranbaxy, India’s largest generic drug manufacturer, agreed to pay $500 million to the United States and thirty-two S - Ex rel - Document - PDFSEARCH.IO

First Page	Meta Content
	United States of America ex rel. Dinesh S. Thakur v. Ranbaxy et al. – Key Facts 1. On May 13, 2013, Ranbaxy, India’s largest generic drug manufacturer, agreed to pay $500 million to the United States and thirty-two S Add to Reading List Document Date: 2013-05-13 12:26:02 Open Document File Size: 26,58 KB Share Result on Facebook

United States of America ex rel. Dinesh S. Thakur v. Ranbaxy et al. – Key Facts 1. On May 13, 2013, Ranbaxy, India’s largest generic drug manufacturer, agreed to pay $500 million to the United States and thirty-two SAdd to Reading List